ImmunoGen
IMGN
#2139
Rank
NZ$15.15 B
Marketcap
NZ$54.24
Share price
0.00%
Change (1 day)
128.80%
Change (1 year)

Market capitalization of ImmunoGen (IMGN)

Last known market cap: NZ$15.15 Billion

On April 12, 2024 ImmunoGen had a market cap of NZ$15.15 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunoGen from 2001 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$15.46 B23.27%
2023NZ$12.54 B627.68%
2022NZ$1.72 B-27.87%
2021NZ$2.39 B37.37%
2020NZ$1.74 B52.94%
2019NZ$1.13 B6.45%
2018NZ$1.06 B-10.43%
2017NZ$1.19 B364.26%
2016NZ$0.25 B-85.1%
2015NZ$1.72 B157.51%
2014NZ$0.67 B-56.16%
2013NZ$1.52 B17.15%
2012NZ$1.30 B15.05%
2011NZ$1.13 B38.9%
2010NZ$0.81 B31.65%
2009NZ$0.62 B65.17%
2008NZ$0.37 B61.55%
2007NZ$0.23 B-22.44%
2006NZ$0.29 B-2.81%
2005NZ$0.30 B-39.04%
2004NZ$0.50 B60.4%
2003NZ$0.31 B26.15%
2002NZ$0.24 B-84.26%
2001NZ$1.58 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Seagen
SGEN
NZ$74.94 B 394.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$306.15 B 1,920.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.668 T 10,909.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$191.58 B 1,164.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$863.49 B 5,599.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$248.73 B 1,541.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$453.40 B 2,892.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$204.24 B 1,248.01%๐Ÿ‡ซ๐Ÿ‡ท France